 Ethics Committee and Israeli Ministry of Health approvals already received for the Companys study with its proprietary SCI-210 treatment TEL AVIV, Israel, Jan. 09, 2023 GLOBE NEWSWIRE SciSparc Ltd. Nasdaq: SPRC Company or SciSparc, a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today... The post SciSparc Signs Agreement to Conduct its Clinical Trial in Autism Spectrum Disorder with Soroka Med... 